Carl Zeiss Meditec AG (LTS:0DHC) Gross-Profit-to-Asset %

: 33.30% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Carl Zeiss Meditec AG's annualized Gross Profit for the quarter that ended in Dec. 2023 was €1,010 Mil. Carl Zeiss Meditec AG's average Total Assets over the quarter that ended in Dec. 2023 was €3,033 Mil. Therefore, Carl Zeiss Meditec AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 33.30%.

Carl Zeiss Meditec AG Gross-Profit-to-Asset % Historical Data

The historical data trend for Carl Zeiss Meditec AG's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Gross-Profit-to-Asset %

45.16

36.95

43.87

43.21

41.18

Carl Zeiss Meditec AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross-Profit-to-Asset %																36.47	42.78	46.26	44.88	33.30

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carl Zeiss Meditec AG Gross-Profit-to-Asset % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Gross-Profit-to-Asset % falls into.

Carl Zeiss Meditec AG Gross-Profit-to-Asset % Calculation

Carl Zeiss Meditec AG's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Sep. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Sep. 2023 )	/	( (Total Assets (A: Sep. 2022 )	+	Total Assets (A: Sep. 2023 ))	/ count )
	=	1205.765	/	( (2822.817	+	3032.924)	/ 2 )
	=	1205.765	/	2927.8705
	=	41.18 %

Carl Zeiss Meditec AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	1010	/	( (3032.924	+	0)	/ 1 )
	=	1010	/	3032.924
	=	33.30 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Carl Zeiss Meditec AG Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Carl Zeiss Meditec AG (LTS:0DHC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (LTS:0DHC) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

CZMWY:USA CZMWF:USA 1AFX:Italy AFXd:UK AFX:Germany AFX:Austria

Address

Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745

Website

https://www.zeiss.com

Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Carl Zeiss Meditec AG (LTS:0DHC) Headlines

No Headlines